Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated R-CHOP ± Radiotherapy: An International Multi-Centre Retrospective Study

July 9, 2019

Allison BarracloughMusa AlzahraniMarianne Schmidt EttrupMark BishtonChris Van VlietLaurie H. SehnVishakha SovaniMitchell Steven WardBradley AugustsonPedro FarinhaJorne Lionel BicclerJoseph M ConnorsDavid W. ScottKerry J SavageTarec Christoffer El-GalalyDiego Villa and Chan Yoon Cheah

Click here for further information